Anzeige
Mehr »
Login
Montag, 25.05.2020 Börsentäglich über 12.000 News von 629 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrFDA names 28 antibody tests to be taken off the market
FrInovio CEO on the COVID-19 vaccine race: Don't count us out
FrSyndax cans FDA filing for lead cancer med after breast cancer bust
FrGenentech posts long-term data on near-approval Soliris rival
FrChutes & Ladders-Warp Speed's Slaoui sells $12M in Moderna stock
FrAstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial
FrThis cancer-related gene may also hold the key to beating obesity
DoGSK taps Mammoth Biosciences to develop a CRISPR-based, over-the-counter coronavirus test
DoKadmon's graft-versus-host disease med on track for 2020 filing
DoNautilus emerges with $76M to become the 'Illumina of proteomics'
DoHarvard animal studies suggest COVID-19 protection can come from previous infection or DNA vaccine
DoSR One fuels HotSpot's $65M B round to fund allosteric R&D
DoDay One debuts with $60M to change cancer care-starting with children
DoGilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
MiCanSino adds mRNA to COVID-19 vaccine efforts with Precision NanoSystems deal
MiApple, Google roll out COVID-19 contact tracing software kit
MiIt's too soon to assume success for Moderna's COVID-19 vaccine: analyst
MiColor gets green light for LAMP-based COVID-19 screening test
MiEiger's progeria drug nabs speedy review
MiAtea raises $215M to support midphase COVID-19 antiviral trial
MiAstraZeneca-partnered RNA player Silence plans Nasdaq listing
DiFDA, Aetion dive into the real-world data surrounding COVID-19
DiPandion recruits Gilead alum Sundy as CMO
DiCell therapy repairs multiple sclerosis damage and restores motor functions in mice
DiInflammatory disease biotech Applied Molecular Transport aims for $100M IPO